Polymerase Chain Reaction for Point-of-Care Diagnostics Market

The global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market was valued at US$ 3665.8 million in 2022 and is projected to reach US$ 6128.6 million by 2029, at a CAGR of 7.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics  market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.

Polymerase Chain Reaction for Point-of-Care Diagnostics Market aims to provide a comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics. Polymerase Chain Reaction for Point-of-Care Diagnostics Market contains market size and forecasts of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in global, including the following market information:

• Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
• Global top five companies in 2022 (%)

We surveyed the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

• Real Time PCR
• DNA/RNA Purification

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

• Key companies Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics revenues share in global market, 2022 (%)

• Abbott Laboratories
• Atlas Genetics
• Cepheid
• Fluxergy
• Roche Diagnostics

Chapter 1: Introduces the definition of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, market overview.

Chapter 2: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size in revenue.

Chapter 3: Detailed analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.